It has been 361 years since anyone has seen a dodo, the odd-looking bird that has become a poster child for extinction. But Colossal Biosciences is hoping to bring them back.
The company, which made headlines less than 18 months ago with its announcement it planned to revive the woolly mammoth, says it will pursue the de-extinction of the iconic bird, using (in part) funds from a Series B funding round that injected another $150 million into the company.
